𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Positron tomographic assessment of androgen receptors in prostatic carcinoma

✍ Scribed by Farrokh Dehdashti; Joel Picus; Jeff M. Michalski; Carmen S. Dence; Barry A. Siegel; John A. Katzenellenbogen; Michael J. Welch

Book ID
105962510
Publisher
Springer
Year
2005
Tongue
English
Weight
166 KB
Volume
32
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

miR 488* inhibits androgen receptor expr
miR 488* inhibits androgen receptor expression in prostate carcinoma cells
✍ Kavleen Sikand; Jinani E. Slaibi; Rajesh Singh; Stephen D. Slane; Girish C. Shuk πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 375 KB

## Abstract Androgen receptor (__AR__) is a ligand‐dependent transcription factor, which plays a significant role in prostate carcinogenesis. Blockade of __AR__ and its ligand, androgen is the basis for the treatment of prostate cancer (PCa). Nevertheless, a modest increase in the critical levels o

Expression, structure, and function of a
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
✍ Culig, Zoran; Hobisch, Alfred; Hittmair, Anton; Peterziel, Heike; Cato, Andrew C πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 2 views

## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o

Synergistic activation of androgen recep
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells
✍ Culig, Zoran; Hobisch, Alfred; Hittmair, Anton; Cronauer, Marcus V.; Radmayr, Ch πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

## Background: We investigated modulation of androgen receptor (ar) activity in prostatic tumor cells by luteinizing hormone-releasing hormone (lhrh)-induced increase of the intracellular cyclic adenosine monophosphate (camp) level. ## Methods: Ar transactivation activity was assessed in transien